Literature DB >> 2024642

GM-CSF in the treatment of Felty syndrome.

G Joseph1, D H Neustadt, J Hamm, M Kellihan, T Hadley.   

Abstract

Many therapeutic agents have been tried with variable success in the treatment of Felty neutropenia, but the reports are anecdotal. We now describe the second trial of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), in a splenectomized, infected patient with Felty syndrome.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2024642     DOI： 10.1002/ajh.2830370114

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  6 in total

1.  Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.

Authors:  A R Gari-Bai; C Rochlitz; M Riewald; J Oertel; D Huhn
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

2.  G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release.

Authors:  R Schots; L A Verbruggen; C Demanet
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

3.  Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash.

Authors:  M F McMullin; M B Finch
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

4.  Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.

Authors:  H Wandt; M Seifert; C Falge; W M Gallmeier
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

5.  GM-CSF and G-CSF in Felty's syndrome.

Authors:  D R Wagner; C Combe; U Gresser
Journal:  Clin Investig       Date:  1993-02

6.  Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF).

Authors:  S Q Hayat; M Hearth-Holmes; R E Wolf
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.